Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Curevac N.V. buy Traumtanz

Start price
€54.30
12.11.20 / 50%
Target price
€57.00
Performance (%)
5.87%
End price
€57.49
12.11.20
Summary
This prediction ended on 12.11.20 with a price of €57.49. The BUY prediction by Traumtanz finished with a performance of 5.87%. Traumtanz has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Curevac N.V. 5.450% 5.450% - -
iShares Core DAX® 1.883% 5.122% 21.667% 22.437%
iShares Nasdaq 100 0.125% 2.574% 45.951% 55.507%
iShares Nikkei 225® -0.201% 4.341% 28.806% 9.945%
iShares S&P 500 0.728% 4.141% 34.630% 50.086%

According to Traumtanz what are the pros and cons of Curevac N.V. for the foreseeable future?

Pros
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
EBIT growth > 30% per year expected
Fair valuation
Standard Investments for future growth
Small cyclical dependencies
Cons

Comments by Traumtanz for this prediction

In the thread Curevac N.V. diskutieren
Prediction Buy
Perf. (%) 5.87%
Target price 57.000
Change
Ends at

Buy mit Kursziel 57,0

In the thread Trading Curevac N.v.
Prediction Buy
Perf. (%) 5.87%
Target price 57.000
Change
Ends at

Buy beendet

Stopped prediction by Traumtanz for Curevac N.V.

buy
Curevac N.V.

Start price
Target price
Perf. (%)
€72.27
28.11.20
-
28.11.21
51.90%
10.12.20

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€65.01
14.11.20
-
6.54%
26.11.20

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€60.99
13.11.20
€63.00
6.59%
14.11.20

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€59.80
13.11.20
€60.00
1.99%
13.11.20

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€57.49
12.11.20
€60.00
4.02%
13.11.20

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€50.44
10.11.20
€55.00
4.48%
12.11.20

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€48.01
10.11.20
€55.00
5.07%
10.11.20

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€45.42
16.10.20
€40.00
04.11.21
5.70%
10.11.20

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Curevac N.V.

Start price
Target price
Perf. (%)
€44.88
16.10.20
€40.00
16.10.20
1.20%
16.10.20

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€68.00
15.08.20
-
19.09.20
-35.29%
19.09.20

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation